"10.1371_journal.pone.0024636","plos one","2011-09-13T00:00:00Z","Yona Goldshmit; Mark D Spanevello; Sophie Tajouri; Li Li; Fiona Rogers; Martin Pearse; Mary Galea; Perry F Bartlett; Andrew W Boyd; Ann M Turnley","Centre for Neuroscience, The University of Melbourne, Parkville, Victoria, Australia; Queensland Institute of Medical Research, Herston, Queensland, Australia; Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia; Department of Medicine, The University of Queensland, Brisbane, Queensland, Australia; CSL Limited, Parkville, Victoria, Australia; Physiotherapy Department, The University of Melbourne, Parkville, Victoria, Australia","Conceived and designed the experiments: YG MDS MG PFB AWB AMT. Performed the experiments: YG MDS ST LL FR. Analyzed the data: YG MDS ST LL FR MG PFB AWB AMT. Contributed reagents/materials/analysis tools: MP MG AWB. Wrote the paper: YG MDS PFB AWB AMT.","The authors have read the journal's policy and have the following conflicts: Martin Pearse is an employee of CSL Limited and who, for the studies described in this manuscript, coordinated the production and quality control of gram quantities of the EphA4-Fc blocker from the EphA4-Fc expression construct as detailed in the methods and provided by Andrew Boyd. Yona Goldshmit, Ann Turnley, Mary Galea, Andrew Boyd and Perry Bartlett have submitted a patent application regarding the use of EphA4 blockers in neural injury, which was sponsored by CSL Ltd (PCT/AU2005/001363). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","09","Yona Goldshmit","YG",10,TRUE,6,5,9,5,TRUE,TRUE,FALSE,0,NA,FALSE
